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Abstract
Neisseria meningitidis is an antigenically and genetically variable Gram-negative bacterium
and a causative agent of meningococcal meningitis and septicaemia. Meningococci encode
many outer membrane proteins, including Opa, Opc, Msf, fHbp and NadA, identified as
being involved in colonisation of the host and evasion of the immune response. Although
vaccines are available for the prevention of some types of meningococcal disease, none cur-
rently offer universal protection. We have used sequences within the Neisseria PubMLST
database to determine the variability of msf and opc in 6,500 isolates. In-silico analysis
revealed that although opc is highly conserved, it is not present in all isolates, with most iso-
lates in clonal complex ST-11 lacking a functional opc. In comparison, msf is found in all
meningococcal isolates, and displays diversity in the N-terminal domain. We identified 20
distinct Msf sequence variants (Msf SV), associated with differences in number of residues
within the putative Vn binding motifs. Moreover, we showed distinct correlations with certain
Msf SVs and isolates associated with either hyperinvasive lineages or those clonal com-
plexes associated with a carriage state. We have demonstrated differences in Vn binding
between three Msf SVs and generated a cross reactive Msf polyclonal antibody. Our study
has highlighted the importance of using large datasets to inform vaccine development and
provide further information on the antigenic diversity exhibited by N. meningitidis.
Introduction
Neisseria meningitidis is an important cause of meningococcal meningitis and septicaemia
worldwide. Case numbers vary geographically with incidence rates up to 14 per 100,000 popu-
lation across Europe, compared to as much as 1,000 per 100,000 population during epidemics
in sub-Saharan Africa [1]. There are 13 distinct serogroups of N. meningitidis, characterised by
differences in the capsular polysaccharide, with six (A, B, C, W-135, X and Y) being associated
with invasive disease. Protein-polysaccharide conjugate vaccines are currently available for the
prevention of meningococcal disease caused by serogroups A, C, W-135 and Y [2, 3]. How-
ever, polysaccharide conjugate vaccines have serious limitations as they are not effective
against strains possessing the serogroup B capsule for example, due to its similarity to human
neuraminic acid [4]. To combat serogroup B disease, a four component vaccine (containing
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Neisserial adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), factor H binding
protein (fHbp), and the outer-membrane vesicles from the New Zealand outbreak strain
NZ98/254) known as Bexsero, was developed [5] and has been licensed for use in the United
Kingdom. Bexsero is estimated to cover 66 to 76% of circulating serogroup B isolates due to
antigenic variation of the components present in the vaccine [6, 7]. Thus, whilst a number of
meningococcal vaccines are available for the prevention of invasive disease, none currently
provide universal protection [2].
N. meningitidis strains are clustered by multi-locus sequencing typing (MLST) into distinct
clonal complexes (cc), comprising of closely related sequence types (ST) [8]. MLST analysis
has highlighted the variability exhibited by meningococci and has led to the identification of
hyperinvasive lineages (e.g. cc ST-8, ST-269, ST-41/44 and ST-11) which are more commonly
associated with invasive meningococcal disease.
Residing in the human nasopharynx, N. meningitidis can disseminate to cause invasive
disease following entry into the blood and central nervous system [9, 10]. Survival in the
body depends on the ability of these bacteria to avoid killing by the innate and adaptive
immune defences. N. meningitidis has a range of surface expressed components, aiding in
colonisation and evasion of the host immune system [9, 11–13]. Such components include,
Opc, fHbp and the trimeric autotransporter adhesins, NadA and Meningococcal surface
fibril (Msf; also referred to as Neisseria hia homologue A, NhhA) [14–16]. Opc is an integral
outer membrane protein, composed of a 10-stranded β-barrel structure with 5 surface
exposed loops [17, 18], required for adherence to, and invasion of eukaryotic cells [12, 19].
Opc is also involved in the evasion of the human immune response, through its ability to
bind to the negative regulator of complement, vitronectin (Vn) [20, 21]. Loop 2 of Opc is
associated with interaction with Vn and monoclonal antibodies binding to this loop results
in significant inhibition of meningococcal binding [17, 21]. Opc binds to the activated form
of vitronectin, requiring sulphated tyrosine Y (56) and Y (59) of the Vn connecting region
[21]. Several studies have identified Opc as a potential vaccine candidate, due to its contribu-
tion to bactericidal activity [22–24].
Msf is a trimeric autotransporter adhesin (TAA) exhibiting similarity to both Hia and Hsf
from Haemophilus influenzae [25–27]. Such proteins are multifunctional surface proteins
involved in biofilm formation, cell adhesion and invasion, auto-aggregation, and survival of
complement mediated killing. Sharing common structural architecture, TAA’s are often com-
posed of three distinct domains; the N-terminal head domain, stalk and β-barrel required to
anchor the protein to the outer membrane [28, 29]. Msf supports adhesion and invasion of epi-
thelial cells [14, 15, 30], as well as modulation of the immune response ensuring maintenance
of carriage [31]. In addition to the outer membrane protein Opc [21], Msf facilitates meningo-
coccal escape of complement-mediated killing via binding to Vn [15, 32], and is known to
bind to matrix proteins such as heparan sulphate and laminin [30]. Although Msf expression
is variable between strains of N. meningitidis [25], its expression is thought to influence host-
pathogen interactions, with its expression being induced in response to epithelial attachment
[30], and in the presence of different iron presentations [33].
The Neisseria PubMLST database (https://pubmlst.org/neisseria/) is an online repository
[34] containing genome and isolate information from a large number of N. meningitidis iso-
lates from all over the globe. This database has been used to determine population structuring
of meningococcal antigens [35]. In our study, we used the PubMLST database to determine
the sequence variability of Msf and Opc in 6,500 meningococcal isolates, and determined their
distribution within different serogroups, and clonal complexes. Generation of this database
has informed this and other in vitro studies and is helping to determine the potential for these
antigens to be used as meningococcal vaccine candidates.
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Materials and methods
Neisseria PubMLST database analysis
The Neisseria PubMLST isolate BIGSdb (https://pubmlst.org/neisseria/) database was used to
determine the conservation of msf and opc between meningococcal isolates [36]. BLAST analy-
sis was performed on 6,500 Neisseria meningitidis isolates using N. meningitidis strain MC58
NMB0992 (msf) or NMB1053 (opc) as our reference genes. Additional information on each
isolates serogroup, clonal complex, disease state and country of origin was also obtained from
the PubMLST BIGSdb.
Alignments and protein sequence analysis
Both the msf and opc nucleotide sequences from each isolate were translated and aligned
by MUSCLE using Mega6 software prior to further manual analysis using BioEdit
software. Msf sequence variants (SV) were described based on increasing number of
amino acids between the conserved motifs previously described to be required for vitronec-
tin binding [32], and were manually assigned for each of the 6,500 meningococcal isolates
in our dataset. Those isolates which only displayed around 28–30% identity to NMB1053
(opc) from MC58, or those having a ‘truncated’ gene (displaying around 45% identity to
MC58 NMB1053), were annotated as Opc negative (–ve). All other isolates showing with
opc genes showing 97–100% sequence identity to NMB1053 we assigned as Opc positive
(+ve).
The daTAA online software (https://toolkit.tuebingen.mpg.de/dataa) was used to predict
the representative structure of the trimeric autotransporter adhesins from N. meningitidis
NMB0992 (Msf), and Haemophilus influenzae Hia (AAL79953) and Hsf (AAX33325) [37].
Bacterial strains and media
All N. meningitidis strains used in this study were grown on brain heart infusion media supple-
mented with 10% horse blood solidified with 1.5% bacteriological agar (HBHI agar) at 37˚C in
5% CO2. Escherichia coli for the expression of recombinant proteins were grown in Lysogeny
broth supplemented with 100 μg/mL ampicillin at 200 rpm (37˚C). N. meningitidis whole cell
lysates were created following resuspension of colonies in distilled water containing 1 x protein
inhibitor cocktail (PIC). Samples were freeze thawed three times and stored at -80˚C until
required.
N-terminal Msf recombinant protein production
Recombinant proteins of the N-terminal domain, amino acid residues 49–189 of Msf-SV types
(SV-1, SV-2, and SV-5) and amino acid residues 31–178 of Msf SV-8, were expressed and puri-
fied from E. coli BL21 (DE3) expression cells. Msf recombinants where cloned into pOPINF
using the Infusion cloning kit (Clontech) following PCR using primers shown in Table 1. The
corresponding plasmid constructs were then transformed into BL21 (DE3) expression cells,
induced using 1 mM IPTG overnight at 20˚C, and purified following a two-step method
involving initial purification through Ni-NTA beads using an imidazole gradient, followed by
ion exchange using a Q sepharose HiTrap column against a NaCl gradient (0–500 mM). This
generated Msf N-terminal recombinant proteins referred to as rMsfSV-149-189, rMsfSV-249-186,
rMsfSV-549-189, and rMsfSV-831-178.
Bioinformatic analysis of Msf and Opc
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Antisera against N-terminal domain of Msf SV-1, SV-2 and SV-5
Antisera was produced by Cambridge Research Biochemicals following a 77 day immunisation
protocol with 2 mg of an equal mix of N-terminal recombinant proteins of Msf SV-1, SV-2
and SV-5 using Freunds complete adjuvant.
Enzyme-linked immunosorbent assay (ELISA)
ELISA plates (96 well, Immulon 2HB) were coated overnight with 100 μL of 3 μM Opc or Msf
N-terminal recombinant proteins (rMsfSV-149-189, rMsfSV-249-186, or rMsfSV-549-189,) in 50
mM carbonate buffer (pH 9.6). Control wells were coated with 3% BSA only. Unbound protein
was removed by washing with ELISA wash (154 mM NaCl containing 0.05% Tween-20). Wells
were blocked with 3% BSA in phosphate buffered saline containing 0.05% Tween-20 (PBST)
for 1h at RT. The wells were then incubated with a final concentration of 2 μg/mL Vn for 1h at
RT. Unbound Vn was removed by washing with ELISA wash and the bound Vn was detected
using anti-vitronectin MsX (8E6 clone, Millipore) and anti-mouse alkaline phosphatase sec-
ondary antibody. ELISA plates were developed using SigmaFast p-nitrophenyl phosphate sub-
strate and the absorbance was measured at 405 nm.
Molecular modelling of the N-terminal domain of Msf
Molecular models of the N-terminal domain of representative sequences of Msf sequence vari-
ant SV-5 and SV-8 were constructed to determine what effect additions of repeating NTN
motifs had on the structure of the vitronectin binding domain. The 10 amino acid (Msf SV-5)
and 14 amino acid (Msf SV-8) loop variants were modelled using our original structural
model of Msf [32], with the insertions built into the N-terminal end of the strand between resi-
dues 120–123 of the canonical or ‘wild-type’ structure (e.g. the sequence of Msf from MC58).
Statistical analysis
Statistical analysis of our dataset of 6,500 isolates was performed using the GraphPad
Prism 7 software. Wilson/Brown analysis was used to determine the proportion of isolates
(expressed as a percentage) being either opc negative or positive, or possessing a distinct
Msf sequence variant type, with confidence intervals (CI) determined to 95% assuming a
binomial distribution.
Ethics statement
Human serum was used as a source of endogenous complement in supplementary figures.
Sera were obtained from the UK NHS Blood and Transplant Service (NHSBT) and derived
from blood donated with consent from healthy adults, where it was identified as surplus to
Table 1. Primers used to clone the N-terminal domain of different Msf sequence.
Primer Sequence (5’-3’)
MC58-MsfFWD AAGTTCTGTTTCAGGGCCCGGCAAGTGCTAACAATGAAGAGC
PMC3-MsfFWD AAGTTCTGTTTCAGGGCCCGGCGAATGCTACCGATGAAGATC
PMC8-MsfFWD AAGTTCTGTTTCAGGGCCCGGCGAATGCTACCGATACCGATG
M07 240646-MsfFWD AAGTTCTGTTTCAGGGCCCGCGAATGCTACCGATGAAGATGA
pOPINF_MsfRV ATGGTCTAGAAAGCTTTACGTATCGGTCAAAGTCGAACC
Primer sequences to allow for cloning into pOPINF are underlined for each forward and reverse primer.
https://doi.org/10.1371/journal.pone.0193940.t001
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clinical requirement or unsuitable for therapeutic use in line with NHSBT processes: http://
hospital.blood.co.uk/components/non-clinical-issue/.
No animals were used in this study. However, animal products used were purchased from
commercial suppliers and were produced conforming to appropriate national guidelines. No
animals were used in this study. However, animal products used were purchased from com-
mercial suppliers and were produced conforming to appropriate national guidelines.
Results
Opc, although not present in all meningococcal isolates, is highly conserved
The role of Opc in serum resistance and adherence to and invasion of epithelial and endothe-
lial cells is well established [12, 21]. Our analysis of 6,500 meningococcal isolates revealed
Opc to be highly conserved, with each Opc positive isolate displaying 97–100% identity to
NMB1053 (Table 1). Out of 6,500 isolates 4,237 were Opc positive, with the remaining 2,263
isolates either lacking or having a truncated form of Opc (Table 2). The majority of opc nega-
tive isolates, which displayed only 28 to 30% sequence identity to NMB1053 due to gene trun-
cation, belonged to serogroups C and W and were associated with the presence of a premature
stop codon. Most of the other serogroups were Opc positive (Table 2). Notably, genome
sequence information is not available for all isolates, so it is possible many strains possessing
opc gene sequences that appeared truncated or lacking from our analysis were in fact Opc posi-
tive, Opc prevalence could therefore be underestimated.
Meningococcal isolates associated with invasive disease are largely grouped into hyperinva-
sive lineages (e.g. clonal complexes (cc) ST-1, ST-4, ST-5, ST-8, ST-11, ST-32, ST-41/44, and
ST-269) [38–40]. In comparison, those isolates predominantly associated with carriage tending
to be associated with clonal complexes distinct from those associated with invasive disease e.g.
ST-23 and ST-35 [38, 41]. Our in-silico analysis revealed 67.12% (CI = 65.2–69.03%) of opc
negative isolates to be in cc ST-11, 12.4% (CI = 11.12–13.84%) to be cc ST-213 and 4.73%
(CI = 3.93–5.68%) belonged to cc ST-461. This absence of opc within isolates from cc ST-11
is thought to contribute to the inability for these isolates to cause infection of the meninges,
with isolates from cc ST-11 primarily associated with severe sepsis [42]. Analysis on
isolates from hyperinvasive lineages and clonal complexes positively associated with carriage,
revealed isolates from invasive disease cc ST-8 (100%; CI = 88.65–100%) and cc ST-11
Table 2. Diversity of Opc in N. meningitidis isolates.
Serogroup Opc+ a Opc- b
A 229 2
B 2294 555
C 302 601
W 132 785
Y 625 2
X 28 3
NG 597 309
E 18 3
H 1 0
Z 11 3
a Meningococcal isolates opc displaying over 97.7% sequence identity to NMB1053 are classed as Opc positive (+).
b Those isolates with an either lacking or having a truncated opc (exhibiting 28.9 to 45.7% identity to NMB1053) were
annotated as Opc negative (-) isolates.
https://doi.org/10.1371/journal.pone.0193940.t002
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(99.92%; CI 99.63–99.99% see S1 Table in Supplementary Information) to lack a functional
copy of opc. In addition, all isolates from cc ST-213 (281 isolates), ST-8 (30 isolates), ST-334
(24 isolates), ST-53 (52 isolates), and 107/108 isolates from ST-461 are opc negative. In com-
parison 96–100% of isolates from hyperinvasive clonal complexes ST-1, ST-4, ST-5, ST-32 and
ST-41/44 and those positively associated with carriage (cc ST-23, cc ST-35 and cc ST-60) were
all Opc positive (see supplementary information S1 Table).
Msf is found in all meningococcal isolates but displays variability within
the N-terminal domain
As Msf supports colonisation and evasion of the immune response, it has potential for inclu-
sion in a meningococcal vaccine [25, 26, 32]. Bioinformatic analysis on 6,500 isolates revealed
Msf to be highly conserved with the most diverse sequences displaying 84% sequence identity
to NMB0992 from MC58 overall (Table 2). Much of the diversity observed is located between
residues 51–200 of the Msf pre-protein (Fig 1).
The Vn binding domain of Msf is predicted to be located within residues 39–82 [32] which
includes the conserved amino acid sequences TLKAGDNLKIKQ and FTYSLKK (Fig 1). These
regions are found in all 6,500 meningococcal isolates analysed and are highly conserved (dis-
playing 99–100% sequence identity; with one amino acid (underlined in bold) change seen in
a small number of strains; e.g. TLKSGDNLKIKQor TLKAGGNLKIKQ). Our analysis revealed
there to be 20 distinct sequence variants (Msf SVs), with variations in both the number and
sequence of amino acid resides between the conserved regions. Notably, a large proportion of
these SVs are due to additions of repeating Asn (N), Thr (T) and Asn (N) residues (Table 3).
Further analysis of our dataset revealed there to be a correlation between Msf SV and pres-
ence/absence of Opc (Table 3). This observation demonstrated a correlation with distinct
clonal complexes. We found that 99.4% of isolates from the hyperinvasive ST-11 complex
encode Msf SV-2 and are opc negative, whereas all 281 isolates from the carriage associated
ST-213 complex are opc negative, with 89% (CI = 85.6–92.7%) of these encoding Msf SV-12.
In addition, less than 50% of isolates encoding longer sequence variants Msf SV-12, Msf SV-15
and Msf SV-17 are Opc positive.
N. meningitidisMsf SV types display distinct correlations with both
serogroup and clonal complexes
Being human restricted, variability in meningococcal surface proteins is thought to have
occurred due to immune selective pressure, with several variants exhibiting non-random over-
lapping associations with distinct clonal complexes. Our analysis has revealed there to be an
association of certain Msf sequence variants with isolates from hyperinvasive lineages and iso-
lates from cc previously associated with a carriage state (Fig 2). The prevalence of Msf sequence
variants was notably different between isolates from hyperinvasive lineages (Fig 2A), which
primarily possess Msf SV-1, SV-2 and SV-5, and those associated with carriage which primar-
ily have Msf SV-11 and SV-12 (Fig 2B). Analysis revealed that 99.5% of isolates from cc ST-11,
predominantly serogroup C and W, were opc negative and encode Msf SV-2 (CI = 98.9–
99.7%, see Fig 2 and S2 Table). In comparison, meningococcal serogroup A isolates, from cc
ST-1, ST-4 and ST-5, encoded Msf SV-5 (Fig 2 and S2 Table). In addition, 151/161 isolates
from cc ST-865, associated in our database with endemic isolates from South Africa, were Opc
positive and encode Msf SV-5. In contrast, Msf SV-1 was largely found in serogroup B isolates
and most commonly seen in isolates from cc ST-32 (33.4%; CI = 30.8–36.1%) and cc ST-269
(25.4%; CI = 23–28%; S1 Table). As seen with other surface antigens, serogroup B isolates
from cc ST-41/44 complex, displayed a more diverse range of Msf SV’s. Although there does
Bioinformatic analysis of Msf and Opc
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not seem to be a distinct Msf SV associated with ST-41/44 there is a predominance for Msf
SV-2, as seen with 50.7% of isolates from this cc (Fig 2 and S2 Table).
In comparison to hyperinvasive lineages, those isolates from clonal complexes associated
with a carriage state, such as cc ST-23 and ST-35, were more commonly found to encode Msf
Fig 1. Amino acid sequence alignment of representative N. meningitidis Msf protein sequences from each defined Msf SV. A) Representative sequences of each of
the Msf SV showing the locations of the signal peptide, predicted Vn binding domain and β-barrel. Different amino acid residues are represented with a different
colour. Position of the G/D and G/S amino acid replacement within the β-barrel, seen in either Msf SV-6 or Msf SV-4, is denoted by the arrow. B) Diagrammatic
representation of variable regions of Msf. Colours denote variable and conserved regions; blue—signal peptide (mostly conserved—exceptions seen with Msf SV-8 and
SV-13); purple—N-terminal variable region; green—variable region between conserved motifs associated with Vn binding; and red—passenger domain (conserved).
Approximate amino acid residue numbers for positions of signal peptide, variable regions are noted in the diagram. Includes location of amino acid residues from
those SVs with ‘shorter’ Msf sequences. Variation in Msf size is largely due to differences within the N-terminal domain of the protein.
https://doi.org/10.1371/journal.pone.0193940.g001
Bioinformatic analysis of Msf and Opc
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SV-11 and SV-12. For example, 95.14% (CI = 93–96.7%) of isolates from ST-23 encoded Msf
SV-11, whereas 71.6% (CI = 61–80.3%) those from cc ST-35 encoded Msf SV-12 (S2 Table).
Sequence analysis predicts certain Msf SVs to be non-functional, due to
amino acid substitutions within the β-barrel, whilst some contain deletions
within the signal peptide
Some meningococcal isolates have been shown to contain a naturally occurring single amino
acid mutation within the β-barrel domain of Msf, specifically a change from a glycine (G) to
an aspartate (D) [43] (see position 581 in Fig 1). This substitution was shown to influence the
trimerisation of the protein, resulting in a monomeric form of Msf corresponding to reduced
surface localisation, adhesion to host cells and reduction in antibody bactericidal killing by
Msf specific antisera [43]. Our bioinformatic analysis has shown that this mutation predomi-
nantly occurs within those isolates encoding Msf SV-6. Moreover, 90.9% of isolates with Msf
SV-6 have this mutation within the β-barrel, with 89.2% (CI = 85–92.3%; see S3 Table) of these
isolates being from cc ST-41/44. Note, 23/286 Msf SV-6 isolates have not been classified into
Table 3. Msf sequence variant distribution among meningococcal isolates.
Sequence between conserved
TLKAGDNLKIKQ and FTYSLKKmotifs
Msf sequence variant (SV) No. of isolates Percent distribution of Msf SV Percent of Opc +ve isolates
NGTN a SV-1 1,203 18% 88%
SGKD  SV-2 2,199 34% 27%
NTNASS SV-3 15 0.2% 87%
NTNDSS c SV-4 26 0.4% 100%
NTNENTNASS SV-5 684 10% 89%
NTNENTNDSS b SV-6 286 4% 98%
NTDENTNASS SV-7 89 1.4% 54%
NTNKNTNENTNDSS d SV-8 434 6.7% 97%
NTNENINENTKASS SV-9 14 0.2% 100%
NTNENTNENTNDSS SV-10 223 3.4% 83%
NTNENTNENTNASS SV-11 705 11% 97%
NTDENTDENTNASS SV-12 522 8% 48%
NTNKNTNENTNENTNDSSd SV-13 3 0.05% 100%
NTNENTNENTNENTNDSS SV-14 30 0.5% 67%
NTNENTNENTNENTNASS SV-15 32 0.5% 34%
NTDENTDENTNENTNASS SV-16 15 0.2% 100%
NTDENTDENTDENTNASS SV-17 7 0.11% 43%
NTNENTNENTNENTNENTNDSS SV-18 5 0.1% 80%
NTNENTNENTNENTNENTNENTNENTNDSS SV-19 4 0.1% 100%
NTNENTNENTNENTNENTNENTNENTNENTNDSS SV-20 2 0.03% 100%
a MC58 NMB0992 was used as query for initial BLAST search on PubMLST;
 Msf-SV used in further in vitro analysis
b 260/286 (90.9%) with Msf SV-6 isolates with the NTNENTNDSSmotif have a G/D replacement in the translocator domain (SMMAIGGD rather than SMMAIGGG). In
addition, 3/30 SV-14 isolates also have this mutation. This naturally occurring single residue mutation, has been shown to affect trimerisation of the protein
(monomeric rather than trimeric form), reduced adherence and cause a defect in surface localisation.
c All isolates with Msf SV-4 have a serine replacement at the same location of the aspartate replacement in the β-barrel (arrow in Fig 1).
d 92% (400/434) with SV-8 and all SV-13 msf nucleotide sequence contains a 14 bp deletion within the 51-aa signal peptide, taking the protein sequence out of frame.
See text for more details.
Number of isolates analysed = 6,500.
https://doi.org/10.1371/journal.pone.0193940.t003
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any cc. This G/D substitution was also observed in 3/30 isolates expressing Msf SV-14. In addi-
tion, we identified that all isolates (with 96% of these isolates being from ST-198) encoding
Msf SV-4 to have a glycine to serine mutation at the same position seen for the G/D (Fig 1).
The consequence of this G/S replacement seen in the β-barrel domain of Msf SV-4 is not cur-
rently known but potentially one could predict this mutation to affect trimerisation, as seen
with the G/D replacement [43].
Autotransporter adhesins are transported via the Sec translocation pathway prior to inser-
tion into the outer membrane, a process achieved by the presence of a signal peptide at the N-
terminus of the pre-protein. Unlike other N-terminal signal peptides, some autotransporters
have unusually long signal peptides, which exhibit a conserved tripartite structure consisting
of an n (N-terminal extension), h (containing hydrophobic residues) and c (containing the sig-
nal SP cleavage site). These long signal peptide sequences in some cases exceeds 50 amino acid
residues, and are known as extended signal peptide sequences (ESPR), which is thought to
play a post-translational role, in regulation of protein export [44–46].
Msf, like many other TAA’s possesses an extended signal peptide sequence (ESPR). Our
analysis revealed 92% (400/434) of isolates encoding Msf SV-8, and those with Msf SV-13,
have a 14 bp deletion within the nucleotide sequence coding for the ESPR (see Fig 3), resulting
Fig 2. Msf sequence variants display correlations with distinct serogroups and clonal complexes of N. meningitidis. A) A large proportion of isolates from clonal
complexes (cc) associated with invasive meningococcal disease (cc ST-5–144 isolates; ST-11–1520 isolates; ST-32–414 isolates; ST-41/44–984 isolates; and ST-269–670
isolates) show a predominance for Msf SV-1 (yellow), SV-2 (orange) or SV-5 (light blue). See supplementary information S2 Table for confidence intervals. B) In
comparison those isolates falling into cc ST-23 (535 isolates) and ST-35 (81 isolates), which positively associate with carriage primarily encode either Msf SV-11 (grey)
or Msf SV-12 (dark blue). C) Prevalence of the most common Msf SVs in invasive N. meningitidis isolates from serogroups A (blue), B (orange), C (green), W (red),
and Y (green). Data shows results of a bioinformatic analysis on 6,500 meningococcal isolates, showing only those Msf SV’s that appear in more than 100 different
isolates.
https://doi.org/10.1371/journal.pone.0193940.g002
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in a premature stop codon not seen any the other Msf sequence variants. Notably if the
sequences were translated in frame 2, utilising an alternate start codon, those same sequences
would code for a full length Msf with a ‘shorter’ signal peptide (predicted SP starting MPEL),
confirmed using SignalP 4.1 online software.
Msf SV-5 displays a significant reduction in vitronectin binding when
compared to Msf SV-1 and Msf SV-2
The predicted Vn binding domain of Msf contains several positively charged residues (e.g.
lysine) thought to exhibit charge complementarity with the negatively charged vitronectin pep-
tide. Given that Msf SV-3 to SV-20 have an increased number of non-charged polar residues
(NTN, Table 2), we hypothesised that the Msf SVs would display differences in Vn binding
due to a change in charge. To test this hypothesis, recombinant proteins (rMsfSV-149-189,
rMsfSV549-189, and rMsfSV249-186) were assayed for Vn binding by ELISA. As predicted
rMsfSV549-189 (which has the motif NTNENTNASS between the conserved TLKAGDNLKIKQ
and FTYSLKKmotifs) showed a significant reduction in Vn binding when compared with
rMsfSV-149-189, rMsfSV249-186 and Opc (Fig 4).
The difference in Vn binding affinity displayed by our Msf recombinant proteins may be
due to structural differences in the previously characterised Vn binding domain located within
Fig 3. A large proportion of isolates encoding Msf-SV-8 have a 14 bp deletion within the ESPR taking the protein out of frame. A) msf nucleotide sequence from
N. meningitidis MC58 (NMB0992 –Msf SV-1) and serogroup B isolates M07 2040646 and M07 240889 (Msf SV-8). Blue arrow—ATG start giving Msf ESPR signal
peptide (translated in frame 1 –see B). Red arrow—possible alternate ATG start (translated in frame 2 –see C). Sequence alignment showed the majority of isolates
with Msf SV-8 to have a 14 bp deletion within the signal peptide (A), resulting in a premature stop codon/protein reading out of frame (B). C) If the second ATG (red
arrow) is used a full length Msf protein could be produced, but with a much shorter signal peptide. Predicted Vn binding domain shown above (in B and C). Asterisk
() indicates premature stop codon.
https://doi.org/10.1371/journal.pone.0193940.g003
Bioinformatic analysis of Msf and Opc
PLOS ONE | https://doi.org/10.1371/journal.pone.0193940 March 16, 2018 10 / 21
the N-terminus of Msf (Table 3, and [32]). To further demonstrate this, we have modelled
both a 10 amino acid loop (for Msf SV-5 to SV-7) and 14 amino acid loop variant (for Msf SV
8 to 12) into our current N-terminal domain model of Msf [32] (Fig 5). Our models indicated
that increasing the number of NTN motifs between the conserved motifs (TLKAGDNLKIKQ
and FTYSLKK) can only be accommodated in the structure by ‘looping out’ within the pre-
dicted Vn binding domain (Fig 5B and 5C). Further functional and structural analyses are
required to validate our molecular models and provide further clues as to the driving force for
the evolution of such diversity in Msf N-terminal domain.
Antisera generated against recombinant proteins of three Msf sequence
variants capable of recognising at least 11 out of 20 Msf SVs
Antisera against full length Msf (TA38), or residues 1–203 (anti-MsfA) from MC58 (15, 32),
revealed a lack of cross reactivity with other Msf variants. Because of the lack of cross reactivity
Fig 4. Msf recombinant proteins of the three predominant Msf SVs associated with hyperinvasive isolates exhibit
differential binding to vitronectin. ELISA Immulon 2HB plates were coated overnight with 3 μM of either Msf
recombinant proteins (rMsf_SV-149-189, blue; rMsf_SV-249-186, green; or rMsf_SV-549-189, red) or purified Opc
(yellow) protein, prior to blocking with 3% BSA. The plates were subsequently overlaid with 0.2 μg vitronectin and
vitronectin binding was detected using anti-Vn monoclonal antibody 8E6 and anti-mouse alkaline phosphatase IgG
(secondary antibody). SIGMAFAST™ p-Nitrophenyl phosphate tablets were used to detect alkaline phosphatase activity
in the ELISA and the absorbance was measured at 405 nm. Results are the average of three independent experiments;
p-values ( 0.01) indicated with  or . Error bars show standard error between replicates.
https://doi.org/10.1371/journal.pone.0193940.g004
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with rMsfSV-549-189, rMsfSV-249-186, immunisations were performed using all three recombi-
nants, generating polyclonal antisera referred to as anti-MsfSV1/2/5. Our anti-MsfSV1/2/5
antibody was able to detected four N-terminal recombinant proteins (rMsfSV-149-189, rMsfSV-
249-186, rMsfSV-549-189, and rMsfSV-831-178), and 11/20 Msf SV expressed by meningococcal
clinical isolates (Table 4 and S2 Fig).
The putative Msf vitronectin binding motif is found in more than one
location within Haemophilus influenzaeHsf and Hia
N. meningitidis Msf displays homology to Hsf and Hia from Haemophilus influenzae, which
play roles in vitronectin binding, serum resistance and adhesion [27, 47, 48]. Due to the
sequence conservation seen between all three TAAs and the repetitive nature of Hia and Hsf,
we decided to examine whether the Msf vitronectin binding motif was present in one or more
locations within both H. influenzae proteins. N. meningitidis Msf (NMB0992) amino acid resi-
dues 1–203 was used for BLAST analysis against Hsf (AAX33325) and Hia (AAL79953), with a
60% or 56% identity seen for each respective protein. Interestingly, both Hia and Hsf showed
Fig 5. Addition of repeating NTN motifs between the conserved predicted Vn binding motifs causes a looping out
of the structure. Ribbon structure and molecular model of the N-terminal Vn binding domain of MC58 Msf (SV-1;
NGTNmotif) (A), 10 amino acid loop variant (e.g. found in Msf SV-5, SV-6 and SV-7) (B), and a 14 amino acid loop
variant (e.g. found in Msf SV-8, SV-9, SV-10, and SV-12) (C). The MC58 Msf molecular (wild-type) model was used to
predict structural differences of the addition of a repeating NTN motif between the conserved TLKAGDNLKIKQ and
FTYSLKKmotifs (B and C), seen for the 10 and 14 residue loop variants. Each chain of the Msf trimer is differently
coloured (blue, red or green) with the location of the NGTN and loop variant motifs shown in yellow.
https://doi.org/10.1371/journal.pone.0193940.g005
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more than one or more homologous regions (two for Hia; six for Hsf) to the predicted Msf
vitronectin binding domain (see Fig 6B–6D for amino acid residue locations), with several
conserved residues seen in between each ‘repeat region’ of Hia, Hsf and Msf. In addition, three
of the ‘repeat’ motifs seen in Hsf (Fig 6D) are located within the vitronectin binding domain of
Hsf; two in Hsf608-1351 and one in Hsf1536-2414 (Fig 6C and 6D) [48].
Discussion
N. meningitidis is a human restricted pathogen that exhibits a high degree of variation, a neces-
sity believed to have evolved to ensure its maintenance of a carriage state, evasion of the host
immune response. However, this variation is can contribute to invasion of host cells and sur-
vival in the blood leading to sepsis and infection of the meninges. The diversiy observed in N.
meningitidis outer membrane proteins poses a significant problem when designing an effective
universal meningococcal vaccine. Hence, although a number of vaccines have been developed,
none provide protection against all meningococcal isolates [2, 3], with Bexsero predicted to
cover 66 to 76% of circulating serogroup B isolates [6, 7]. Universal meningococcal vaccine
coverage is further complicated by the global distribution of different clonal complexes and by
the occurrence of capsule switching [7, 49].
N. meningitidis outer-membrane proteins are known to exhibit variable expression levels,
with a 15-fold difference in expression seen for fHbp [50]. Although the expression of Msf is
Table 4. Antiserum generated against Msf SV-1, SV-2, and SV-5 is cross reactive.
Isolates Serogroup Msf-SV a Western blot result d % of isolates with Msf SV e
N-terminal recombinant proteins
rMsfSV-149-189
b - SV-1 ++ 18.4%
rMsfSV-249-189
b - SV-2 ++ 33.8%
rMsfSV-549-186
b - SV-5 ++ 10.4%
rMsfSV-831-178
b - SV-8 ++ 6.6%
N. meningitidis clinical isolates
MC58 c B SV-1 ++ 18.4%
PMC3 c A SV-5 + 10.4%
PMC8 c C SV-2 + 33.8%
PMC9 C SV-11 +++ 10.8%
PMC14 C SV-14 +++ 0.5%
M07 240646 c B SV-8 - 6.6%
M07 240789 B SV-9 + 0.21%
M07 240680 B SV-10 + 3.4%
M07 240909 B SV-12 ++ 8%
M07 240669 B SV-6 ++ 4.5%
M07 240949 B SV-3 + 0.2%
a Isolate Msf SV determined by PCR and sequencing, later confirmed for some of the meningococcal isolates by genome sequencing
b N-terminal Msf recombinant proteins, rMsfSV-149-189, rMsfSV-249-186, rMsfSV-549−189, and rMsfSV-831-178, were expressed in E. coli and purified as previously
described (see Methods).
c Strains used for cloning and expression of N-terminal domain of different Msf-SVs as recombinant proteins. Lack of msf expression seen for M07 240646 is likely due
to the presence of a 14 bp deletion within the coding region for the signal peptide, resulting in a premature stop codon.
d Western blot analysis indicating relative level of expression (- = no detectable expression; + = low levels of expression detected; ++ = good expression level; +++ = high
levels of expression). See S2 Fig for raw data.
e Prevalence of meningococcal isolates with Msf-SV from Neisseria PubMLST analysis on 6,500 meningococcal isolates.
https://doi.org/10.1371/journal.pone.0193940.t004
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known to vary between strains of N. meningitidis [25], Msf has been shown to be upregulated
in response to epithelial attachment [30] and changes in iron presentation [33].
Diversity of meningococcal outer-membrane proteins is known to result in the lack of gen-
eration of cross reactive antibodies, making production of a universal vaccine difficult. To
Fig 6. Domain annotation and location of repeat regions of homology seen between N. meningitidis Msf and H. influenzaeHia and Hsf. The architecture of the
trimeric autotransporter adhesin N. meningitidis Msf (A), and Hia AAL79953 (B) and Hsf AAX33325 (C) from H. influenzae was predicted using dTAA online
software. dTAA domain annotations; blue–signal peptide; red—Trp ring; grey—GANG; yellow—KG; green—neck; pink—connector (ISneck); light blue—TTT; light
green—YadA like head. Approximate positions of sequences aligning to the Msf vitronectin binding domain (VnBD) (see sequences in D) indicated in brackets.
Previously identified VnBD for Msf (amino acid resides 90–133, (32)) and Hsf (amino acid residues 608–1351 and 1536–2414; [48]) shown under each respective
diagram. Diagram is not drawn to scale. N and C-terminus of each protein sequence are indicated. D) Sequence alignment of ‘repeat’ regions seen in Hia and Hsf, with
two repeat regions seen for Hia, and six for Hsf. Consensus sequence shows residues conserved between all sequences within the alignment.
https://doi.org/10.1371/journal.pone.0193940.g006
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highlight this difficulty, antibodies raised against NadA variant 4 do not recognise any other
NadA variants, and although bactericidal activity is seen against NadA4, only very low levels of
bactericidal killing seen against meningococci expressing alternate variants [51].
As msf is present in all meningococcal isolates sequenced to date, is expressed in vivo, elicits
bactericidal antibodies and provides serum resistance, it is regarded, along with opc, as a
potential candidate for inclusion in a universal vaccine [15, 21, 25, 26, 32]. In addition to our
previous studies, we have shown that antibodies generated against the Vn binding domains
of Msf SV-1, SV-2 and SV-5 (anti-MsfSV1/2/5) and a synthetic peptide of Opc loop 2 (anti-
Opcloop2-KLH), display serum bactericidal and function blocking activity (see Supplementary
information and S1 Fig). In addition, we have shown our anti-MsfSV1/2/5 antibody to be
cross reactive, recognising 11/20 Msf sequence variants. Both Msf and Opc exhibit variable
expression levels, with differences in opc expression being due to phase variation [12, 30, 52].
Previously, simultaneous expression of Msf and Opc has been shown to impart an increase in
serum resistance and vitronectin binding, when compared to expression of either Msf or Opc
alone [15]. Our analysis has revealed that the absence of opc for the most part is correlated
with the presence of Msf SV-2, with the majority of isolates with this phenotype being from cc
ST-11.
Although N. meningitidis outer membrane proteins, such fHbp and NadA, are known to
display a high degree of antigenic variation, distinct associations with clonal complexes and
sequence variants have been observed [53–55]. FHbp, found in all meningococcal isolates, is
required for modulation of the immune response by binding to human factor H, a negative reg-
ulator of the alternate complement pathway. PorA, FetA, NadA and fHbp sequence variants,
exhibit non-random, non-overlapping association with distinct clonal complexes [35, 40, 53–
57]. This highly structured diversity of antigenic variants is thought to have evolved through
strong immune selection leading to stable dominant selection of alleles at different antigenic
loci [35, 40]. Interestingly, our analysis revealed there to be a similar association with distinct
Msf SVs and certain serogroups and clonal complexes (Fig 2). For example, isolates from cc
ST-11, previously associated with fHbp peptide 22 and NadA variant 29 [54, 55], predomi-
nantly have Msf SV-2 but lack opc. In comparison isolates from ST-1, ST-4 and ST-5, responsi-
ble for meningococcal epidemics/pandemics in sub-Saharan Africa [40, 58], are associated with
fHbp variant 1 [55], and predominantly have Msf SV-5 and are Opc positive (S2 Table).
This association between outer membrane protein variant type and clonal complex is
thought to be due to the high degree of genetic stability exhibited by meningococci [53]. For
example, immunogenic antigens in serogroup A isolates associated with cc ST-5 have been
shown to be highly conserved, suggesting evasion of the immune response is not linked to
emergence of epidemic waves in sub-Saharan Africa meningitis belt [40]. However, while
genes encoding immunogenic antigens (including fHbp, NadA and Opc) are largely con-
served, allelic differences in genes required for metabolic functions and environmental and
genetic information processing have been seen between different pandemic waves of cc ST-5
[40]. Indeed, associations between clonal complexes and protein variant types of Msf (this
study), as well as fHbp and NadA have been observed [57, 59]. For example, ST-32 isolates
tend to have NadA1 and fHbp sub-variant 1.1 and are commonly associated with Msf SV-1,
whereas NadA2 and NadA3 being more commonly found with cc ST-11 (which predomi-
nantly has Msf SV-2; S2 Table) and ST-8 (predominantly Msf SV-10; S2 Table) [59]. Our anal-
ysis has shown a clear distinction in Msf SV type with isolates associated with either invasive
disease or carriage. This is illustrated in the case of Msf SV-1, SV-2 and SV-5 which are largely
associated with invasive isolates (e.g. cc ST-8, ST-11, ST-269 and ST-41/44) and Msf SV-11
and SV-12 being associated with cc ST-23, ST-35, ST-60 and ST-22 which are commonly
associated with carriage (Fig 2, S2 and S3 Tables). Whilst isolates used in this study represented
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58 different countries, it should be noted that the majority of isolates from the PubMLST
BIGSdb are from the UK hence may not truly represent the global distribution of Msf and
Opc. Further information on the isolates used in this study is provided in S4 Table to facilitate
further analyses.
Our analysis has indicated that three variant types (Msf SV-6, Msf SV-8 and Msf SV-13)
found in ~11% of meningococcal isolates in our database, may not be efficiently expressed/
exported to the outer-membrane, due to either a mutation within the β-barrel or a 14 bp dele-
tion within the sequence encoding the ESPR (Table 3, Figs 2 and 3). Considering all other Msf
SV have the full length 51 aa signal peptide, ESPR are required for proper translocation of
TAA’s to the outer-membrane. No detectable in vitro expression of clinical isolates encoding
Msf SV-8 was observed and, as anti-MsfSV1/2/5 is able to detect rMsfSV-831−178, one can pre-
dict there to have been an immune selective pressure for this 14 bp deletion (S2 Fig). It is
important to note that out of the 434 isolates that encode either a predicted Msf SV-8 or SV-13
only 11 lack Opc, and the clear majority of isolates are from clonal complex ST-269 (79.95%;
CI = 75.932–83.45%—S3 Table), suggesting a selection advantage in expression of at least one
vitronectin binding protein. In addition, those isolates encoding Msf SV-6, largely associated
with cc ST-41/44, are also Opc positive. The predicted lack of expression of this Msf sequence
variant may be compensated for by Opc, which performs similar functions as Msf e.g. in terms
of vitronectin binding and adherence to host cells.
Our analysis has shown a difference in Msf vitronectin binding capabilities exhibited by
Msf SV-1, SV-2 and SV-5, with the presence of repeating NTN motifs causing a predicted
structural alternation resulting in a reduction in Vn binding, as seen with rMsfSV-549-186 (Figs
4 and 5). We propose that the Msf sequence variants (described in Table 2) have evolved as
consequence of immune selection pressure, balanced with selection to maintain function, in
this case binding to vitronectin, and hence is linked to the evolution of clonal complexes. Our
results indicate that an increased number of repeating NTN motifs result in the reduction/loss
of vitronectin binding capability and ‘looping out’ of the structure, compensated for by the
presence of Opc which performs similar functions. This ‘looping out’ of the N-terminal
domain has precedent, and has been observed in N-terminal structure of the trimeric auto-
transporter adhesin NadA [56]. There are, however, exceptions to this hypothesis as isolates
found in cc ST-213 and cc ST-8 lack opc and encode Msf sequence variants predicted not to
bind to Vn as well as Msf SV-1 and SV-2. For example, 89% of isolates from cc ST-213 encode
Msf SV-12, and 70% of cc ST-8 isolates encode Msf SV-10, which, due to the presence of multi-
ple NTN motifs within the Vn binding domain and predicted structural changes, may display
a significant reduction in vitronectin binding affinity (Table 2, Figs 4 and 5). It is also plausible
that ST-8 and 213 complex isolates may have further adaptations allowing immune evasion.
Further functional and structural work into the Msf sequence is required to validate these pre-
dictions. It may be possible that the NTN repeat motifs provide an advantage to meningococci.
For example, NTN repeats and the NTNENTNENTNASS sequence (seen in Msf SV-11) are also
found within asparagine-rich antigen (locus SBT70246) from Plasmodium malariae. Plasmo-
dium asparagine-rich proteins have been shown to regulate sporozoite gene expression and
liver stage development, and are required for induction of a protective immune response [60].
N. meningitidis Msf displays homology to Hsf and Hia from H. influenzae. In comparison
to Msf, Hia and Hsf are much larger and are known to have repetitive architecture (protein
monomers; Msf ~62 kDa, Hia ~114 kDa and Hsf ~250 kDa). Hia has been shown to display
repetitive architecture, containing two binding pockets which display varying affinities for epi-
thelial cell attachment [61, 62]. Hsf is conserved among all typeable H. influenzae isolates and,
like N. meningitidis Msf, binds Vn and is required for survival within human serum [48]. H.
influenzae Hsf forms a unique twisted hair-pin like structure, with the N-terminal domain
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located near the C-terminus at the base of the trimeric fibril structure [63], having two
distinct vitronectin binding domains located within Hsf608-1351 and Hsf1536-2414 [48] (Fig 6C).
Although two vitronectin binding domains were identified [48], an alternate study identified
Hsf binding domain 2 (BD2), located at the N-terminus, to serve as the major vitronectin
binding domain of Hsf (64). Hsf AAX33325 Vn BD1 and BD2 (Fig 6C and 6D) BD2 [64], con-
tains the three motifs showing homology to the putative Msf Vn binding domain. Comparison
of the putative Msf vitronectin binding domain with Hia and Hsf revealed the conservation of
a T(n)KAG(n)K(n)K motif (consensus sequence in Fig 6D) in the putative vitronectin binding
domain both Msf and Hsf, with Hsf having these motifs at both the N and C-terminus. Indeed,
lysine resides K66 and K68 of the mature Msf protein have been implicated in vitronectin
binding, with a KIK66-68-AIA mutation causing a reduced Vn binding affinity [32]. These
two lysines form part of the consensus sequence seen in Fig 6D, indicating that these residues
could also be required for Vn binding in both N. meningitidis Msf and H. influenzae Hsf.
Conclusions
This study has highlighted the importance of using large scale bioinformatic datasets to gain a
greater understanding of the variability exhibited by meningococcal outer-membrane adhe-
sins. Analysis of over 6,000 meningococcal isolates has revealed there to be 20 distinct Msf
sequence variants, defined by our group as having increasing number of amino acid residues
between two highly conserved motifs previously associated with Vn binding (32). We have
shown the Msf sequence variants to display correlations with distinct serogroups, clonal com-
plexes and presence/absence of opc, shown three recombinant Msf proteins to display differ-
ences in vitronectin binding affinity, and have generated a cross reactive antibody capable of
recognising at least 11/20 Msf sequence variants, which displays both serum bactericidal and
function blocking activity.
We envisage that use of Msf and Opc as vaccine antigens could potentially provide much
broader vaccine coverage. Indeed, our bioinformatic analysis has indicated that if both Msf
and/or Opc are expressed in vivo, and antibodies generated against both the vitronectin bind-
ing domains of Msf SV-1, SV-2 and SV-5 and Opc are bactericidal, a vaccine containing these
proteins could provide protection against 98% of meningococcal isolates. Further work how-
ever is required to validate this prediction. We believe using large scale in silico analysis to
determine the variability exhibited by putative meningococcal vaccine candidates is a key step
in the creation of an effective and universal vaccine to prevent meningococcal disease.
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